CompletedPhase 3NCT01353313

Hydrocortisone for BPD

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
NICHD Neonatal Research Network
Principal Investigator
Michele C Walsh, MD
Case Western Reserve University, Rainbow Babies and Children's Hospital
Intervention
Hydrocortisone(drug)
Enrollment
800 enrolled
Eligibility
All sexes
Timeline
20112024

Study locations (20)

Collaborators

National Center for Research Resources (NCRR) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Heart, Lung, and Blood Institute (NHLBI) · National Center for Advancing Translational Sciences (NCATS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01353313 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials